Montez LC tablets represent an advanced pharmaceutical formulation combining Levocetirizine Hydrochloride 5mg and Montelukast Sodium equivalent to Montelukast 10mg. This dual-mecha...

Montez LC tablets represent an advanced pharmaceutical formulation combining Levocetirizine Hydrochloride 5mg and Montelukast Sodium equivalent to Montelukast 10mg. This dual-mechanism therapy addresses the complex pathophysiology of allergic conditions through complementary actions, providing comprehensive symptom relief. The uncoated tablet design ensures rapid dissolution and consistent bioavailability, making it suitable for patients aged 15 years and older. Manufactured under strict quality control standards, each tablet maintains precise dosage accuracy and therapeutic reliability while utilizing pharmaceutical-grade excipients that enhance stability and patient tolerance.

This medication serves diverse healthcare settings including allergy specialty clinics, pulmonary medicine practices, hospitals, and general healthcare facilities. Medical institutions utilize Montez LC for managing patients with comorbid asthma and allergic rhinitis, particularly those requiring preventive care during high-allergy seasons. Pharmaceutical distributors supply this product to retail pharmacies, hospital pharmacies, and healthcare networks serving populations with significant allergy prevalence. The treatment proves especially valuable in regions with distinct seasonal variations where allergic rhinitis incidence peaks during specific periods, providing consistent relief when patients need it most.

Business partners benefit from our commitment to manufacturing excellence and supply chain reliability, ensuring consistent product availability and quality. Our GMP-compliant processes and rigorous quality assurance protocols guarantee every batch meets stringent pharmaceutical standards. The formulation's clear contraindications, including hypersensitivity to components and specific metabolic conditions, provide healthcare professionals with comprehensive safety information. This transparency builds trust with medical practitioners and end-users while ensuring appropriate patient selection and treatment outcomes.

Key Features:
- Precise combination of Levocetirizine 5mg and Montelukast 10mg per tablet
- Uncoated tablet design for rapid dissolution and absorption
- ALU ALU packaging ensuring optimal product protection and shelf life
- Manufactured under strict GMP compliance and quality control standards
- Clear contraindication guidelines for patient safety

Benefits:
- Dual-action relief addressing both allergy and asthma symptoms
- Once-daily dosing for improved patient compliance
- Consistent therapeutic performance across treatment periods
- Reliable quality backed by manufacturing excellence
- Comprehensive safety information for healthcare providers